Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia
AUTOR(ES)
Marshall, John K.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=116151Documentos Relacionados
- Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization
- Why is calling an ACE an ACE so controversial? Evaluating reference-based pricing in British Columbia
- Pharmaceutical cost containment with reference-based pricing: time for refinements
- Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs
- Reference-based refinements